Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 4Polycystic Ovary Syndrome 1Pain 1Lung Neoplasms 1Insulin Resistance 1Fatigue 1Dyspnea 1Colorectal Neoplasms 1Anxiety Disorders 1

Interventions

Fluorouracil 71pembrolizumab 62Bevacizumab 60Oxaliplatin 59Cetuximab 59Leucovorin 56Irinotecan 55Capecitabine 31Nivolumab 23Gemcitabine 18Cisplatin 18IFL protocol 17Folfox protocol 17Cyclophosphamide 16Carboplatin 15atezolizumab 14Specimen Handling 14Paclitaxel 14Magnetic Resonance Spectroscopy 14Biopsy 14trifluridine tipiracil drug combination 12Pemetrexed 10spartalizumab 9regorafenib 9fludarabine 9Panitumumab 9130-nm albumin-bound paclitaxel 9trametinib 8durvalumab 8dehydroftorafur 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Colorectal Neoplasms × Acupuncture Therapy × Clear all
NCT00034034 2007-01-05

Acupuncture to Reduce Symptoms of Advanced Colorectal Cancer

National Center for Complementary and Integrative Health (NCCIH)

Phase 1 Completed
105 enrolled
Gastrointestinal

Anxiety Disorders, Pain, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡